期刊文献+

非酒精性脂肪性肝病兔肝组织甘油三酯、丙二醛、超氧化物歧化酶与血浆内皮素的关系 被引量:4

Relations of triglyceride,malondialdehyde and superoxide dismutase in the rabbit liver tissue,ET-1 in the plasma with nonalcoholic fatty liver disease
原文传递
导出
摘要 目的检测非酒精性脂肪性肝病(NAFLD)兔肝组织甘油三酯(TG)、丙二醛(MDA)、超氧化物歧化酶(SOD)浓度与血浆内皮素-1(ET-1)之间的关系,探讨TG、MDA、SOD与ET-1在NAFLD发病中的相互作用。方法 40只日本大耳白兔数字法随机分为重度NAFLD组(重度组)、轻度NAFLD组(轻度组)、空白对照组(对照组)。重度组给予高脂饲料160g·兔-1·d-1,轻度组给予高脂饲料80g·兔-1·d-1+普通饲料80g·兔-1·d-1,对照组给予普通饲料160g·兔-1·d-1。饲养13周。实验前后采集血浆标本,检测TG、胆固醇(TC)、ET-1;检测肝组织匀浆MDA、SOD、TG浓度;肝组织HE染色,光镜观察肝脏病理学。结果 (1)血浆TC、TG:饲养后重度组TC、TG分别为(32.12±1.25)mmol/L、(6.02±2.12)mmol/L,轻度组分别为(18.34±2.10)mmol/L、(4.39±1.93)mmol/L,与饲养前比较差异有统计学意义(P<0.01);重度组TG、TC高于轻度组(P<0.01)。(2)肝组织TG:重度组(0.71±0.07)mmol/L、轻度组(0.52±0.08)mmol/L,与对照组(0.29±0.10)mmol/L比较差异有统计学意义(P<0.01),重度组与轻度组比较差异有统计学意义(P<0.01)。(3)肝组织MDA浓度:重度组(219.87±25.57)nmol·mg-1·pro-1、轻度组(154.91±26.98)nmol·mg-1·pro-1,与对照组(99.95±20.87)nmol·mg-1·pro-1比较差异有统计学意义(P<0.01),重度组与轻度组比较差异有统计学意义(P<0.01)。(4)肝组织SOD活性:重度组(27.49±8.17)nU·mg-1·pro-1、轻度组(48.76±7.37)nU·mg-1·pro-1,与对照组(64.47±7.89)nU·mg-1·pro-1比较差异有统计学意义(P<0.01),重度组与轻度组比较差异有统计学意义(P<0.01)。(5)血浆ET-1浓度:重度组、轻度组ET-1明显上升,与对照组比较差异均有统计学意义(P<0.01),重度组与轻度组比较差异有统计学意义(P<0.05)。(6)肝脏病理学:重度组呈重度NAFLD,轻度组呈轻、中度NAFLD,对照组为正常肝脏组织。结论 TG沉积量、脂质过氧化及血浆ET-1参与NAFLD的发生、发展,降低TG在肝脏的沉积,抑制过氧化反应,降低血浆ET-1浓度对抑制NAFLD的发生、发展有重要作用。 Objective To observe the relationships of triglyceride, malondialdehyde, superoxide dismutase in the rabbit liver tissue, and ET-1 in the plasma with nonalcoholic fatty liver disease, discusses the effects of TG, MDA, and SOD in the occurrence of NAFLD. Methods 40 Japanese white rabbits were randomly divided into severe group with NAFLD ( severe group), mild group with NAFLD ( mild group), blank control group(blank group). Severe group was given high fat diet 160 g -1. rabbit-1 · day-1 , mild group were given high fat diet 80 g· rabbit- 1 . day- 1and normal diet 80 g · rabbit- 1 · day- 1, blank group was given normal diet 160 g·rabbit-1·day-1 The raising cycle is 13 weeks. Plasma samples were collected before and after experiment, tested triglyceride (TG) and cholesterol(TC). The density of MDA, SOD, TG in liver tissue were tested. HE staining, pathological changes of liver tissue were observed with the aid of light microscope. Results ( 1 ) TC and TG level: after the feeding severe group of TC and TG respectively is (32. 12 ± 1.25)mmol/L, (6. 02 ± 2. 12)mmol/L, mild group of TC and TG respectively is ( 18.34 ±2. 10) mmol/L, (4. 39± 1.93 ) mmol/L, After the feeding, there was a significant difference compared in every group (P〈0. 01). Severe group of TG and TC higher than mild group, there was a significant difference compared (P 〈 0. 01 ). (2) The level of TG in liver tissue : Severe group of TG in liver tissue is (0.71 ± 0. 07 )mmol/L, mild group of TG in liver tissue is (0. 52± 0. 08)mmolfL, there was a significant difference compared with blank control group (P 〈 0. 01 ), blank group of TG in liver tissue is (0. 29 ±0. 10) mmol/L, there was a significant difference between severe group and mild group ( P 〈 0.01 ). (3) The level of MDA in liver tissue : Severe group of MDA in liver tissue is (219. 87 ± 25. 57 ) nmol· mg-1· pro -1, mild group of MDA in liver tissue is (154. 91 ± 26. 98) nmol·mg-1· pro-1 , blank group of MDA in liver tissue is (99.95 ±20. 87) nmol · mg-1· pro-1, there was a significant difference compared with blank group (P 〈0. 01 ), there was a significant difference between severe group and mild group( P 〈 0. 01 ). (4)The level of SOD in liver tissue: Severe group of SOD in liver tissue is (27.49 ± 8. 17)nmol·mg-1· pro-1 , mild group of SOD in liver tissue is (48.76 ±7.37) nmol· mg-1· pro-1 , blank group of SOD in liver tissue is (64. 47 ± 7. 89 ) nmol· mg - 1·Pro - 1, there was a significant difference compared with blank group (P 〈 0. 01 ), there was a significant difference between severe group and mild group (P 〈 0. 01 ). (5)The level of ET-1 in the plasma: Severe group and mild group significantly decreased in the plasma, there was a significant difference compared with blank group(P 〈0. 01 ), there was a significant difference between severe group and mild group (P 〈 0. 05 ). (6) Liver pathology: severe group of moderate was severe NAFLD, mild group was mild to moderate NAFLD, blank group was normal liver. Conclusions Triglyceride deposition amount, lipid peroxidation and plasma ET-1 participated the occurrence and development of NAFLD, they are very important to reduce the amount of triglyceride in liver, inhibit the peroxidation, reduce the level of plasma ET-1 for restraining the occurrence and development of NAFLD.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第4期25-28,974,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 湖北省教育厅科技项目(D20102104) 湖北省卫生厅科研项目(JX5B75) 十堰市科技局科技项目(2010st33) 2010年湖北医药学院学生科研项目(2010XSA019)
关键词 脂肪肝 甘油三酯类 超氧化物歧化酶 丙二醛 内皮缩血管肽1 Fatty liver Triglycerides Superoxide dismutase Malondialdehyde Endothelin-1
  • 相关文献

参考文献13

二级参考文献73

共引文献250

同被引文献36

  • 1张频,王雪芬,龚作炯,陈瑞.腺苷蛋氨酸对酒精性脂肪肝大鼠治疗效果及机制的研究[J].山东医药,2005,45(32):21-23. 被引量:2
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 3Marko Duvnjak,Ivan Leroti,Neven Bari,Vedran Tomai,Lucija Virovi Juki,Vedran Velagi.Pathogenesis and management issues for non-alcoholic fatty liver disease[J].World Journal of Gastroenterology,2007,13(34):4539-4550. 被引量:74
  • 4任燚,肖庆贵,邬吉伟,陈大吉.酒精性肝病临床流调现状.现代保健?医学创新研究 2008,5:55-56.
  • 5Gao B,Bataller R.Alcoholic liver disease:pathogenesis and new therapeutic targets.Gastroenterology,2011,141:1572-1585.
  • 6Kawai D,Takaki A,Nakatsuka A,Wada J,Tamaki N,Yasunaka T,Koike K,Tsuzaki R,Matsumoto K,Miyake Y,Shiraha H,Morita M,Makino H,Yamamoto K.Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.Hepatology,2012,56:912-921.
  • 7McClain C,Barve S,Joshi-Barve S,Song Z,Deaciuc I,Chen T,Hill D.Dysregulated cytokine metabolism,altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease.Alcohol Clin Exp Res 2005,29:180S-188S.
  • 8Mann RE,Smart RG,Govoni R.The epidemiology of alcoholic liver disease.Alcohol Res Health 2003,27:209-219 PubMed.
  • 9Morgan K,French SW,Morgan TR.Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage.Hepatology 2002,36:122-134.
  • 10Rao RK,Seth A,Sheth P.Recent Advances in Alcoholic Liver Disease I.Role of intestinal permeability and endotoxemia in alcoholic liver disease.Am J Physiol Gastrointest Liver Physiol 2004,286:G881-G884.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部